Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-01-22

Clinical Trial Update: Phase II Study of Digitoxin to Treat Cystic Fibrosis [Phase 2]

View source ↗

Summary

Phase II trial update for digitoxin in cystic fibrosis has completed and results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Digitoxin (digitoxin)

Snippet

Sponsor: National Jewish Health | Conditions: Cystic Fibrosis | Phase 2 | Status: COMPLETED | Results posted: 2016-01-22